Assembly process of machine recognition form. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Process of steel truss incremental launching. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

CGAN and AutoML stacking device. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Comprehensive prediction process of shape errors. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Shape error manual calculation process. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

U-wave estimates versus R-matrix noise variance. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Sliding window process. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Original record form of error matrix. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Form for machine recognition. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

RMSE versus architectural parameters. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Kalman process. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Attention mechanism. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Shape error measurement results statistics. by Zhe Hu (787283)

“…Then, the LSTM model is trained using this sliding window approach, achieving a root mean square error(RMSE) of 0.03 on the test set. …”

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”

Data Sheet 1_The TFRC as a prognostic biomarker and potential therapeutic target in cervical cancer: a preliminary study.docx by Jing Wang (6206297)

“…We constructed a nomogram model, TFRC contributed significantly to the prognosis and exhibited good predictive power for the OS and the DSS. …”

Fig 9 - by David G. Morgan (1459003)